Skip to content

Tri-Ad™ 900SFC234Recalls & reported problems

Medtronic, Inc. · BAND 900SFC234 TRI-AD2.0 ADAMS TRICUSPID · Class 2 · Implant

All models of Tri-Ad (12)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
5
Deaths reported
0
Injuries reported
5
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00763000102340), received between Aug 31, 2023 and Sep 30, 2026 — classified as 5 injuries.

The most frequently reported specific device problem is “Patient Device Interaction Problem” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 1 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 1 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 1 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 1 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2
  • Patient Device Interaction Problem2
  • Insufficient Device Problem Information1

Patient problems

  • Insufficient Information3
  • Non specific EKG/ECG Changes2
  • Atrial Fibrillation1

Recent adverse event reports

The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.

  • InjurySep 30, 2026Patient Device Interaction Problem

    Medtronic received information that 1 month post implant of this 34mm tricuspid band and this 38mm mitral annuloplasty band, a Bi-Ventricular defibrillator was implanted. The reason for the Bi-Ventricular defibrillator was reported as low ejection fraction (EF). No additional adverse patient effects were reported.

    Patient problems: Non specific EKG/ECG Changes

    MAUDE report 50943046 ↗
  • InjuryMar 19, 2026Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT DURING THE IMPLANT OF THIS 34MM TRICUSPID ANNULOPLASTY BAND, IT WAS EXPLANTED AN REPLACED WITH A 33MM MITRAL BI OPROSTHETIC VALVE IN THE TRICUSPID POSITION. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Insufficient Information

    MAUDE report 24637381 ↗
  • InjuryDec 11, 2025Patient Device Interaction Problem; Patient Device Interaction Problem

    IT WAS REPORTED THAT 7 DAYS POST IMPLANT OF THIS 34MM ANNULOPLASTY BAND AND 21 YEARS AND 10 MONTHS POST IMPLANT OF THIS 29MM MITRAL BIOPROSTHETIC VALVE, A PERMANENT PACEMAKER WAS REPORTED. THE REASON FOR THE PERMANENT PACEMAKER WAS REPORTED AS LOW EJECTION FRACTION (EF). NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Insufficient Information

    MAUDE report 23775981 ↗
  • InjuryAug 27, 2024Insufficient Device Problem Information; Insufficient Device Problem Information

    MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT OF THIS 34MM TRICUSPID ANNULOPLASTY BAND, IT WAS EXPLANTED AND REPLACED WITH AN UNKNOWN PRODUCT. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Insufficient Information

    MAUDE report 20075757 ↗
  • InjuryAug 31, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    MEDTRONIC RECEIVED INFORMATION THAT 3 DAYS POST IMPLANT OF THIS 34MM TRICUSPID ANNULOPLASTY BAND, ATRIAL FLUTTER WITH VARIABLE ATRIO -VENTRICULAR BLOCK WAS OBSERVED ON A ELECTROCARDIOGRAM. NO INTRACARDIAC THROMBUS WAS OBSERVED. CARDIOVERSION WAS PERFORMED 1 DAY FOLLOWING THIS OBSERVATION. 3 DAYS FOLLOWING TREATMENT, AN ELECTROCARDIOGRAM REVEALED ONGOING ATRIAL FIBRILLATION WITH RAPID VENTRICULAR RESPONSES. IT WAS STATED THAT THE ATRIAL FIBRILLATION AND ATRIAL FLUTTER WAS RELATED TO THE PROCEDURE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Atrial Fibrillation; Non specific EKG/ECG Changes

    MAUDE report 17664183 ↗

Other RING, ANNULOPLASTY devices

All RING, ANNULOPLASTY devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page